Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Spironolactone helps regrow hair in women with hair loss.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Researchers created rat liver stem cells that could help repair liver failure in rats and may be useful for studying human liver diseases.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Melatonin improves cashmere goat hair growth and quality by increasing antioxidants and reducing cell death.

Plant steroid hormones show growth, health, and medicinal benefits in various organisms, including potential for treating diseases.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Adrenal disorders can cause lasting brain and behavior issues in children.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

ΔNp63α helps control a protein that stops cancer cells from spreading.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.